Jazz Pharmaceuticals JAZZ Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's goodwill?
- Jazz Pharmaceuticals (JAZZ) reported goodwill of $1.81B in Q1 2026.
- How has Jazz Pharmaceuticals's goodwill changed year-over-year?
- Jazz Pharmaceuticals's goodwill increased by 2.6% year-over-year, from $1.76B to $1.81B.
- What is the long-term trend for Jazz Pharmaceuticals's goodwill?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's goodwill has grown at a 13.8% compound annual growth rate (CAGR), from $958.3M to $1.83B.
- What does goodwill mean?
- The excess amount paid for an acquisition over the fair value of its net assets.
- How do you interpret goodwill?
- An increase indicates recent M&A activity, while a decrease suggests impairment charges due to underperforming acquisitions.
- How does goodwill compare across companies?
- Common in growth-by-acquisition biopharma firms; high levels indicate a history of significant M&A.